CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
50 hedge funds and large institutions have $58M invested in Concert Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
16
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$4.03M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
$2.36M |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
$1.84M |
| 4 |
Bank of New York Mellon
New York
|
$723K |
| 5 |
Citigroup
New York
|
$582K |
